The Technical Analyst
REMSleep Holdings, Inc. [RMSL]
Exchange: PNK Industry: Medical Devices
REMSleep Holdings, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.43% $0.0117
America/New_York / 3 mai 2024 @ 15:58
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 17.10 mill |
| EPS: | 0.0100 |
| P/E: | 1.170 |
| Earnings Date: | May 13, 2024 |
| SharesOutstanding: | 1 461.62 mill |
| Avg Daily Volume: | 1.754 mill |
| RATING 2024-05-03 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 1.170 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 1.170 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.0003 (-97.28%) $-0.0114 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0097 - 0.0137 ( +/- 17.09%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2017-06-29 | Bird Russell Finlay | Sell | 0 | Common Stock |
| 2017-06-29 | Bird Russell Finlay | Sell | 1 500 000 | Preferred A |
| 2017-06-29 | Wood Tom J | Sell | 0 | Common shares |
| 2017-06-29 | Wood Tom J | Sell | 2 000 000 | Preferred A |
| 2012-04-18 | Sullivan Matthew | Sell | 0 | COMMON STOCK, PAR VALUE $.001 |
| INSIDER POWER |
|---|
| 0.00 |
| Last 11 transactions |
| Buy: 270 055 000 | Sell: 3 500 000 |
Forecast:
16:00 - $0.0117
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $0.0117
Forecast 2: 16:00 - $0.0117
Forecast 3: 16:00 - $0.0117
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.0117 (0.43% ) |
| Volume | 1.977 mill |
| Avg. Vol. | 1.754 mill |
| % of Avg. Vol | 112.74 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For RMSL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
RMSL
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. The company is headquartered in Tampa, Florida.
Latest Press Releases
2024-03-06 11:48:00 - Press Release
Remsleep Holdings Patent Status
Clearwater, fl, march 06, 2024 (globe newswire) -- via newmediawire - remsleep holdings, inc. (otcqb: rmsl) is awarded new patent.
2024-03-04 15:08:00 - Press Release
Remsleep Holdings Shareholder Update
Clearwater, fl, march 04, 2024 (globe newswire) -- via newmediawire - remsleep holdings, inc. (otc pink: rmsl) gives an update on fda process and remsleep status. we have had numerous inquiries asking for remsleep regulatory status update. remsleep was asked to answer questions and perform added shelf-life testing. we have initiated the shelf-life testing and are waiting on results. we hope to get test results in the next six weeks. then we have to resubmit the results. we believe we submitted the perfect 510(k) application and were stunned the agency requests more information. we were fortunate to find the top expert for 510(k) submissions and he is now on-board with remsleep going forward, which will make a huge difference in guiding us to the finish line.
2024-01-22 11:12:28 - Press Release
Remsleep Holdings Inc.'s Deltawave Mask Has Received Questions From Fda Regarding 510k Submission (k233415)
Tampa, fl, january 22, 2024 – remsleep holdings inc. (otcqb: rmsl), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea (osa) has received a response to the company's 510(k) submission k233415. the agency has determined that additional information is required.
2024-01-22 11:07:00 - Press Release
Remsleep Holdings Inc.'s Deltawave Mask Has Received Questions From Fda Regarding 510k Submission (k233415)
Tampa, fla., jan. 22, 2024 (globe newswire) -- remsleep holdings inc. (otcqb: rmsl), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea (osa) has received a response to the company's 510(k) submission k233415.
2023-11-02 08:01:29 - Press Release
Remsleep Holdings Inc.'s Deltawave Mask Moves To Substantive Review Of Fda 510k Process
Tampa, fl, november 2, 2023 – remsleep holdings inc. (otcqb: rmsl), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea (osa) patients, is pleased to announce its deltawave mask has moved to the substantive review portion of the fda 510k review process.